Biotechnology Market to Grow at a CAGR of 14.10% During 2026-2035, Driven by the Increasing Adoption of Gene Editing Technologies Across the Global

Biotechnology Market Overview

Biotechnology involves the use of living organisms and biological systems to develop products and technologies that improve human health, agriculture, and the environment. It integrates genetics, molecular biology, and biochemistry to create innovative solutions in medicine, food production, and industrial processes. The market is rapidly expanding due to advancements in genetic engineering, increasing investments, and growing demand for personalized medicine. It plays a crucial role in healthcare innovation, agricultural improvements, and sustainable industrial applications, driving significant economic growth globally.

Key Findings

• Biopharma dealmaking reached record levels in 2025, with announced global biotech deals totalling USD 228.4 billion, up from USD 132.3 billion in 2024, according to Dealogic, as large drugmakers raced to rebuild pipelines in oncology and gene therapy ahead of upcoming patent cliffs.
• In 2026, the US Food and Drug Administration approved the first new molecular entity under its new National Priority Voucher program, a scheme that compresses review timelines to as little as one to two months for designated therapies, accelerating time to market for prioritized biotechnology treatments.
• US biomanufacturing investment expanded significantly, with multi-year US capital commitments announced by large biopharmaceutical companies, including AbbVie at around USD 10 billion, driven by trade and tariff policy incentives to base production domestically.

Biotechnology Market Demand Drivers

The market is significantly driven by the increasing global prevalence of cardiovascular diseases (CVDs), which the World Health Organization  (WHO) identifies as the leading cause of death, accounting for an estimated 17.9 million fatalities annually (2024). This urgency has led governments worldwide to implement targeted healthcare initiatives and increase funding for biotechnology research and development. Additionally, according to data from PIB Delhi (January 2025), India is rapidly advancing its biotechnology sector, fueled by the BIO-E3 policy and a significant bioeconomy expansion from USD 10 billion in 2014 to USD 130 billion in 2024. This growth is fostering innovation and driving advanced research. Together, these factors are fueling substantial technological advancements and ongoing growth in the global biotechnology market.

Biotechnology Market Segmentation Analysis

PCR Technology to Hold a Significant Market Share for Segmentation by Technology

Among the various technologies, PCR is expected to hold a significant share of the biotechnology market due to its critical applications in diagnostics, genetic research, and disease surveillance. For instance, in September 2024, Takara  Bio USA’s recent launch of the SmartChip ND real-time PCR System, a high-throughput, flexible platform for antimicrobial resistance monitoring, demonstrates the expanding scope and demand for advanced PCR solutions. This innovation underscores PCR technology’s pivotal role in driving market growth. Other key technologies in the market include nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, fermentation, chromatography, and others.

The market report also offers insights based on the application, end user, product type and region.

Biotechnology Market: Competitive Landscape

• In February 2026, Gilead Sciences, headquartered in Foster City, California, agreed to acquire Arcellx for up to USD 7.8 billion, including about USD 6.6 billion in cash, adding the CAR-T cell therapy anito-cel for multiple myeloma. Gilead completed the acquisition in late April 2026, deepening its move beyond its HIV roots into cell therapy.
• In February 2026, Bristol-Myers Squibb forecast an upbeat 2026, reporting fourth-quarter 2025 revenue of USD 12.5 billion and guiding to full-year 2026 adjusted earnings of USD 6.05 to USD 6.35 per share, supported by immuno-oncology growth. It also expanded its lentiviral vector supply agreement with Oxford Biomedica for cell and gene therapies.
• Other players involved in the market include AstraZeneca, Sanofi, Biogen, Pfizer, Inc., Amgen Inc., Novo Nordisk A/S, Merck KGaA, and Johnson & Johnson Services, Inc.

Biotechnology Market Analysis by Region

North America is Projected to Lead the Market Share

The global biotechnology market is primarily segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America is expected to lead the market, driven by substantial government support, advanced research infrastructure, and large-scale private investments. In September 2023, the Biden-Harris  Administration launched an action plan to expand and diversify the United States' biomanufacturing workforce, enhancing the region’s leadership. Europe and Asia Pacific also experience significant growth, fueled by rising healthcare needs, technological advancements, and expanding biotech hubs. 

Key Offerings of the Report

• The EMR report gives an overview of the market for biotechnology for the period (2019-2025) and (2026-2035). 
• The report also offers historical (2019-2025) and forecast (2026-2035) market information for the technology, application, and region of the market.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790